Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2025-09-29 Regulatory Filings
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to the stock exchange (BSE Limited) regarding the closure of the trading window for insiders in compliance with insider trading regulations. It specifies the period during which trading in the company's shares is prohibited for designated employees and their relatives, linked to the upcoming declaration of unaudited financial results for the quarter and half year ended September 30, 2025. The document does not contain any financial data, results, or detailed report content itself, but is an announcement related to trading restrictions ahead of financial disclosures. Given the short length (1504 characters) and the nature of the content as an official notification to the exchange, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-09-29 English
General Updates
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the resignation of the Company Secretary and Compliance Officer of LASA Supergenerics Limited. It includes the resignation letter and details required under SEBI (LODR) Regulations, 2015. There is no financial data, earnings information, or report attached or referenced as being published. The content is clearly about a management change, specifically the resignation of a senior officer. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and focused solely on this announcement, confirming it is not a full report or other filing type.
2025-09-22 English
Updates
Regulatory Filings
2025-09-12 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal communication from Lasa Supergenerics Limited to stock exchanges (BSE and NSE) dated September 5, 2025. It announces the outcome of a Board Meeting held on the same day. The key points include approval of the Notice of the 10th Annual General Meeting (AGM), scheduling of the AGM, approval of the Director's Report, Corporate Governance Report, Management Discussion and Analysis Report for the financial year ended March 31, 2025, appointment of a scrutinizer for the AGM, re-appointment of a director, and closure of the register of members. The document also includes detailed information about the re-appointed director as an annexure. The document does not contain the full Annual Report or financial statements but announces the approval and upcoming AGM. It is a regulatory announcement about board decisions and AGM arrangements, not the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting outcomes and director re-appointment details.
2025-09-05 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed report of the voting results from a Postal Ballot conducted through remote e-voting for LASA Supergenerics Limited. It includes the resolution passed (appointment of an Executive Director), voting statistics, and a scrutinizer's report confirming the validity and outcome of the vote. The document references compliance with SEBI Listing Regulations and Companies Act, 2013, and provides detailed voting data and the scrutinizer's certification. This type of document is an official declaration of voting results from a shareholder meeting or postal ballot, not a management report, annual report, or other financial filing. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content confirm it is not a brief announcement or a proxy solicitation but a full voting result report. Confidence is high due to the clear presence of voting results, scrutinizer report, and regulatory references specific to voting disclosures.
2025-09-03 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is a detailed report of the voting results from a Postal Ballot conducted through remote e-voting for LASA Supergenerics Limited. It includes the resolution passed (appointment of an Executive Director), voting statistics, and a scrutinizer's report confirming the validity and outcome of the vote. The document references compliance with SEBI Listing Regulations and Companies Act, 2013, and provides detailed voting data and procedural information. It is not an announcement of a report publication but the actual voting results and scrutinizer's report. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a regulatory filing. Therefore, the classification is DVA with high confidence.
2025-09-03 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.